Joseph S. Zakrzewski serves as Executive at DOV PHARMACEUTICAL INC, where they oversee executive responsibilities. Since joining the company, Joseph S. Zakrzewski has executed 130 insider transactions totaling $53.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 6, 2024 involved exercising options for 14,150 shares valued at $23.9K.
Joseph S. Zakrzewski currently holds 227,439 shares of DOV PHARMACEUTICAL INC (DOVP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph S. Zakrzewski has been a net seller of DOVP stock. They have purchased $777.5K and sold $52.7M worth of shares.
Joseph S. Zakrzewski's most recent insider trade was on Feb 6, 2024, when they sold 14,150 shares at $1.69 per share.
Get notified when new Form 4 filings are submitted
| $19.11 |
| Discretionary |
| Dec 7, 2022 | CYT | $27.6K | Purchase | 21,202 | $1.30 | Discretionary |
| May 12, 2022 | CYT | $1.2K | Purchase | 743 | $1.61 | Discretionary |
| May 11, 2022 | CYT | $1.7K | Purchase | 1,000 | $1.70 | Discretionary |
| May 10, 2022 | CYT | $93.4K | Purchase | 49,406 | $1.89 | Discretionary |
| Mar 29, 2022 | ANTX | $0 | Conversion | 98,199 | $N/A | Discretionary |
| Feb 25, 2022 | SGMO | $0 | Award | 12,500 | $N/A | Discretionary |
| Dec 28, 2021 | CYT | $5.9K | Purchase | 601 | $9.85 | Discretionary |
| Dec 27, 2021 | CYT | $1.0K | Purchase | 99 | $10.18 | Discretionary |
| Dec 27, 2021 | CYT | $2.0K | Purchase | 200 | $9.97 | Discretionary |
| Dec 23, 2021 | CYT | $2.0K | Purchase | 200 | $9.87 | Discretionary |
| Dec 17, 2021 | CYT | $2.0K | Purchase | 200 | $9.88 | Discretionary |
| Dec 15, 2021 | CYT | $20.9K | Purchase | 2,000 | $10.47 | Discretionary |
| Dec 15, 2021 | CYT | $18.9K | Purchase | 1,700 | $11.12 | Discretionary |
| Dec 15, 2021 | AMRN | $6.3K | Purchase | 2,000 | $3.16 | Discretionary |
| Dec 14, 2021 | AMRN | $32.7K | Purchase | 10,000 | $3.27 | Discretionary |
| Nov 19, 2021 | XLRN | $0 | Tender | 34,499 | $N/A | Discretionary |
| Jun 22, 2021 | CYT | $0 | Conversion | 58,671 | $N/A | Discretionary |
| Apr 5, 2021 | XLRN | $946.8K | Sale | 6,748 | $140.31 | Discretionary |
| Apr 5, 2021 | XLRN | $241.1K | Option Exercise | 10,000 | $24.11 | Discretionary |
| Apr 5, 2021 | XLRN | $156.5K | Sale | 1,100 | $142.27 | Discretionary |
| Apr 5, 2021 | XLRN | $304.0K | Sale | 2,152 | $141.28 | Discretionary |
| Apr 1, 2021 | XLRN | $229.9K | Sale | 1,700 | $135.22 | Discretionary |
| Apr 1, 2021 | XLRN | $885.6K | Sale | 6,596 | $134.27 | Discretionary |
| Apr 1, 2021 | XLRN | $217.1K | Sale | 1,600 | $135.67 | Discretionary |
| Apr 1, 2021 | XLRN | $241.1K | Option Exercise | 10,000 | $24.11 | Discretionary |
| Apr 1, 2021 | XLRN | $13.8K | Sale | 104 | $132.61 | Discretionary |
| Feb 25, 2021 | SGMO | $0 | Award | 8,200 | $N/A | Discretionary |
| Jan 29, 2021 | XLRN | $0 | Award | 1,622 | $N/A | Discretionary |